Fisher & Paykel Healthcare Corporation Limited, traded on OTCMKTS under the symbol FSPKF, is a New Zealand–based medical device manufacturer specializing in respiratory support and sleep therapy solutions. Established as a division of Fisher & Paykel Appliances in the late 1980s and spun off as an independent public company in 2001, the firm is headquartered in Auckland and maintains a global footprint in clinical care.
The company’s core product portfolio encompasses humidification systems for patients receiving mechanical ventilation, non-invasive ventilation devices, and continuous positive airway pressure (CPAP) machines with associated interfaces such as masks and breathing circuits. Beyond acute care offerings, Fisher & Paykel Healthcare develops neonatal care products, high-flow therapy systems for adult and pediatric patients, and surgical humidification solutions. A significant emphasis on research and development enables the company to refine product designs, enhance patient comfort, and improve clinical outcomes.
Serving customers in more than 120 countries, Fisher & Paykel Healthcare has major markets across North America, Europe and the Asia-Pacific region. It operates manufacturing facilities in New Zealand and Mexico, and distributes products through a combination of direct sales teams and regional partners. Under the leadership of CEO Lewis Gradon and a board of directors with deep expertise in medical technology and healthcare, the company continues to drive innovation, expand its footprint, and support clinicians and patients around the world.
AI Generated. May Contain Errors.
